{
    "code": "02024592",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024592",
    "time": "2019-10-11 03:21:37",
    "許可證字號": "衛署藥輸字第024592號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/01\/12",
    "發證日期": "96\/01\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202459201",
    "中文品名": "博脈舒加強錠16毫克\/12.5毫克",
    "英文品名": "Blopress 16mg Plus 12.5mg Tablets",
    "適應症": "本態性高血壓，以Candesartan cilexetil或Hydrochlorothiazide單獨治療無法有效控制的本態性高血壓。",
    "劑型": "110錠劑",
    "包裝": "2-1000錠鋁箔盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
    "主製造廠": {
        "申請商名稱": "1406701100  台灣武田藥品工業股份有限公司",
        "申請商地址": "台北市信義區松高路1號17樓",
        "主製造廠": "",
        "製造廠名稱": "FIT0344000  DELPHARM NOVARA S.R.L."
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6133061413  歐帕生技醫藥股份有限公司",
            "製造廠廠址": "新竹縣湖口鄉光復路1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝及分裝"
        },
        {
            "製造廠名稱": "FDE0264000  (LICENCE HOLDER) TAKEDA PHARMA GMBH.",
            "製造廠廠址": "VIKTORIAALLEE 3-5 D-52066 AACHEN GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "總公司"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005710",
            "成分名稱": "CANDESARTAN CILEXETIL",
            "含量描述": "",
            "含量": "16.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4028100600",
            "成分名稱": "HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
            "含量描述": "",
            "含量": "12.5000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淡紅色",
        "特殊氣味": "",
        "刻痕": "有",
        "形狀": "橢圓形",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Blopress 16 mg Plus 外觀-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024592&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Blopress plus 16+12.5mg_Chinese PI_EU SmPC_2015 Mar_20190731-108-08-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024592&Seq=005&Type=9"
        },
        {
            "title": "03_中文仿單_Blopress Plus 16mg+12.5mg Leaflet rev1-105-04-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024592&Seq=003&Type=9"
        },
        {
            "title": "Blopress 16mg PLUS 外盒-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024592&Seq=006&Type=8"
        }
    ]
}